AnteoTech Limited (ASX:ADO)

Market Cap	46.37M
Revenue (ttm)	968.88K
Net Income (ttm)	-6.76M
Shares Out	2.73B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	165,392
Average Volume	1,288,653
Open	0.0160
Previous Close	0.0170
Day's Range	0.0160 - 0.0160
52-Week Range	0.0070 - 0.0280
Beta	1.35
RSI	39.34
Earnings Date	Feb 26, 2026

About AnteoTech

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company’s products include AnteoBind, a metal-ion complex-based activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit, a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micr...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Merrill Gray
• Employees: 99
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ADO

Financial Performance

In 2025, AnteoTech's revenue was 968,878, an increase of 110.44% compared to the previous year's 460,397. Losses were -6.76 million, -23.89% less than in 2024.